- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Price disconnect
Taiwanese Pharmaceuticals & Biotech Price disconnect
Results
6
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
6 companies
TTY Biopharm
Market Cap: NT$18.8b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.
4105
NT$75.70
7D
-1.7%
1Y
-1.7%
Standard Chemical & Pharmaceutical
Market Cap: NT$11.4b
Manufactures and sells pharmaceutical products in Taiwan and internationally.
1720
NT$57.80
7D
0.1%
1Y
10.6%
Cenra
Market Cap: NT$4.8b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$33.15
7D
-4.3%
1Y
-2.2%
TSH Biopharm
Market Cap: NT$1.9b
Develops and markets pharmaceutical products in Taiwan.
8432
NT$48.80
7D
-2.6%
1Y
2.0%
Taiwan Advance Bio-Pharmaceutical
Market Cap: NT$855.0m
Operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.
4186
NT$9.50
7D
-3.3%
1Y
-10.4%
Bioray Biotech
Market Cap: NT$605.0m
Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.
7561
NT$20.45
7D
0%
1Y
-16.9%